Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectus Sheath Block in Pediatric Appendicitis
NCT04717193Phase 2Completed
- Sponsor
- University of Alberta
- Start
- May 2021
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of bupivacaine in appendicitis (2 arms), sponsored by University of Alberta. Primary endpoint: Faces Pain Scale - Revised at 3 hours post-operatively. Started May 2021; status: completed.
02
Drugs
bupivacaine
03
Conditions
appendicitis
Beyond the preview
Go deeper on NCT04717193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04717193.